Novel Monoclonal Antibodies Against the Proximal (Carboxy-Terminal) Portions of MUC16
- 1 October 2010
- journal article
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 18 (5) , 462-472
Abstract
The CA125 antigen, recognized by the OC125 antibody, is a tissue-specific circulating antigen expressed in ovarian cancer. The CA125 antigen is encoded by the MUC16 gene cloned by Yin and Lloyd. The full-length gene describes a complex tethered mucin protein present primarily in a variety of gynecologic tissues, especially neoplasms. OC125 and other related antibodies react with glycosylation-dependent antigens present exclusively in the cleaved portion of the molecule. These antibodies are not useful as screening tools, nor can they detect the proximal residual MUC16 protein fragment after cleavage. This has limited its diagnostic and therapeutic applications. Using synthetic peptides, we raised novel-specific antibodies to the carboxy-terminal portion of MUC16 retained by the cell proximal to the putative cleavage site. These antibodies were characterized using fluorescence-activated cell-sorting analysis, enzyme-linked immunoassay, Western blot analysis, and immunohistochemistry. Each of the selected monoclonal antibodies was reactive against recombinant GST-ΔMUC16 protein and the MUC16-transfected SKOV3 cell line. Three antibodies, 4H11, 9C9, and 4A5 antibodies showed high affinities by Western blot analysis and saturation-binding studies of transfected-SKOV3 cells and displayed antibody internalization. Immunohistochemical positivity with novel antibody 4H11 was similar to OC125 but with important differences, including diffuse positivity in lobular breast cancer and a small percentage of OC125-negative ovarian carcinomas that showed intense and diffuse 4H11. Development of such antibodies may be useful for the characterization of MUC16 biology and allow for future studies in targeted therapy and diagnostics.Keywords
This publication has 29 references indexed in Scilit:
- Current state of biomarker development for clinical application in epithelial ovarian cancerGynecologic Oncology, 2010
- A Binding Domain on Mesothelin for CA125/MUC16Journal of Biological Chemistry, 2009
- MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast CellsCancer Research, 2008
- MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cellsBritish Journal of Cancer, 2008
- Histologic Subtypes of Ovarian CarcinomaInternational Journal of Gynecological Pathology, 2008
- Muc4–ErbB2 Complex Formation and Signaling in Polarized CACO-2 Epithelial Cells Indicate That Muc4 Acts as an Unorthodox Ligand for ErbB2Molecular Biology of the Cell, 2006
- Epitopes on CA 125 from Cervical Mucus and Ascites Fluid and Characterization of Six New AntibodiesTumor Biology, 2002
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- CA125 Phosphorylation Is Associated with Its Secretion from the WISH Human Amnion Cell LineTumor Biology, 1997
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983